Il mercato ePRO, diari elettronici e eCOA è stato valutato a 1.342,92 milioni di dollari nel 2020 e si prevede che crescerà a un CAGR del 15,1% nel periodo 2021-2028.
L'utilizzo della valutazione elettronica dei risultati clinici (eCOA) rappresenta una spinta verso l'adattamento della "nuova normalità" alla realtà aziendale. poiché si tratta di un metodo per raccogliere elettronicamente i dati dei pazienti utilizzando tecnologie come dispositivi domestici intelligenti, monitor portatili, dispositivi indossabili, diari elettronici, tablet e server Web per consentire alle parti interessate (pazienti, volontari sani, ricercatori e operatori sanitari) di partecipare agli studi per segnalare i risultati direttamente e digitalmente. Sebbene storicamente il COA fosse correlato solo alla valutazione dei risultati correlati al paziente (PRO), la FDA ha ora ampliato la definizione per includere PerfO, ClinRO e ObsRO insieme a PRO. In termini semplici, quando i parametri di cui sopra vengono riportati elettronicamente, rientrano nello spettro eCOA.
La piattaforma eCOA/ePRO presenta vantaggi sostanziali per sponsor e CRO, poiché riduce gli oneri amministrativi, mitiga i costi e accelera i processi. Tale sistema mostra ottimi risultati con meno errori e discrepanze, migliore qualità dei dati, segnali più chiari e studi accurati standardizzati. Fattori come la crescente adozione delle cartelle cliniche elettroniche e le normative governative che impongono la conservazione delle cartelle cliniche guidano la crescita del mercato ePRO, dei diari elettronici dei pazienti e dell'eCOA.
Regioni redditizie per ePRO, ePatient Diaries ed eCOA Market
Approfondimenti di mercato
Crescente domanda di sperimentazioni cliniche
Secondo i dati forniti da Clinicaltrials.gov, il 2016 è stato un anno importante per la ricerca clinica. A febbraio 2021 erano circa 366.000 gli studi clinici registrati a livello globale. Gli studi clinici sono una parte essenziale dello sviluppo di farmaci in tutto il mondo. Il numero di studi clinici è aumentato in modo significativo poiché nel 2000 ne sono stati segnalati solo 2.119. Di questi, quasi la metà sono sperimentazioni farmacologiche o biologiche (123.806), con 45.501 che attualmente reclutano partecipanti. Al momento, ci sono 43 terapie in Fase II per COVID-19. Le società impegnate nello sviluppo sono AstraZeneca plc; Arch Biopartners Inc.; Terapia applicata Inc.; Apeiron Biologics GmbH; 4D Pharma plc; e AB Science SA. Le aziende stanno collaborando con altre aziende per accelerare lo sviluppo di terapie e vaccini. Ad esempio, Eli Lilly ha collaborato con AbCellera per sviluppare vaccini; GSK, Novartis e MSD stanno lavorando con la Fondazione Bill e Melinda Gates. GSK e Sanofi stanno lavorando insieme per sviluppare un vaccino anti-COVID-19 adiuvato.
Inoltre, l'epidemia di COVID-19 ha creato un'urgenza ancora maggiore affinché gli studi clinici diventino più efficaci. virtuale e offrire ai pazienti un'esperienza sicura e conveniente. Pertanto, gli operatori del mercato stanno lanciando nuovi prodotti, guidando così l’adozione di piattaforme incentrate sul paziente. Ad esempio, Veeva Systems ha annunciato MyVeeva for Patients, una nuova applicazione per i siti di ricerca clinica. Con funzionalità per visite virtuali, adesione dei pazienti, ePRO, eConsent, eSource e un ePRO, ePatient Diaries ed eCOA di facile utilizzo, MyVeeva for Patients renderà più semplice per i siti di ricerca clinica fornire un servizio clinico incentrato sul paziente e senza supporti cartacei. esperienza di sperimentazione per pazienti e sponsor. Inoltre, nel gennaio 2021 YPrime, LLC, ha annunciato il lancio della piattaforma elettronica di valutazione dei risultati clinici (eCOA) di quinta generazione. La sua piattaforma più recente offre un'esperienza utente migliorata per pazienti, ricercatori clinici, sponsor e CRO. Questa tecnologia avanzata migliora l'efficienza degli studi clinici, aumenta la soddisfazione del centro e migliora la compliance dei pazienti. Questa versione garantisce inoltre la fornitura di dati più chiari, semplificando la raccolta dei dati degli studi clinici e il processo di approvazione.
Tipo di approfondimenti basati sulla soluzione
In base al tipo di soluzione, il mercato ePRO, diari elettronici dei pazienti ed eCOA è segmentato in eCOA (Electronic Clinical Outcome Assessments), ePROs (Patient Reported Outcomes), ClinROs (Clinician Reported Outcomes), ObsROs (Observer Reported Outcomes), PerfOs (Performance Risultati), Diari elettronici del paziente. Il segmento eCOA ha detenuto la quota maggiore del mercato nel 2020. Tuttavia, si stima che il segmento ePRO registrerà il CAGR più elevato nel mercato durante il periodo di previsione.
Globale ePRO, ePatient Diaries e mercato eCOA, per tipo di soluzione: 2020 e 2028
Approfondimenti basati sulla modalità
Basati sulla modalità, sull'ePRO, sui diari dei pazienti e il mercato dell’eCOA è biforcato in computer e dispositivi mobili. Il segmento dei dispositivi mobili ha detenuto una quota maggiore del mercato nel 2020. Inoltre, si stima che lo stesso segmento registrerà un CAGR più elevato nel mercato durante il periodo di previsione.
Approfondimenti basati sull'utente finale
In base all'utente finale, il mercato ePRO, diari elettronici dei pazienti ed eCOA è segmentato in sponsor di sperimentazioni cliniche, contratto organizzazioni di ricerca (CRO), ospedali, istituti accademici, aziende farmaceutiche e altri. Il segmento degli sponsor delle sperimentazioni cliniche ha detenuto la quota maggiore del mercato nel 2020 e si stima che registrerà il CAGR più elevato del 15,5% nel mercato durante il periodo di previsione.
Approfondimenti strategici
Varie aziende che operano nel mercato ePRO, diari elettronici ed eCOA adottano strategie come lanci di prodotti, fusioni e acquisizioni, collaborazioni, innovazioni di prodotto ed espansioni del portafoglio prodotti per espandere la propria presenza in tutto il mondo, mantenere la marchio e soddisfare la crescente domanda da parte degli utenti finali.
ePRO, diari ePatient e mercato eCOA - per tipo di soluzione
- Valutazioni degli esiti clinici
- Esiti riferiti dai pazienti
- Esiti riferiti dal medico
- Esiti riferiti dall'osservatore
- Risultati prestazionali
- Diari ePatient
ePRO, diari ePatient e mercato eCOA - per modalità
- Computer
- Dispositivi mobili
ePRO, diari ePatient e mercato eCOA - per utente finale
- Sponsor della sperimentazione clinica
- Organizzazioni di ricerca a contratto
- Ospedali
- Istituti accademici
- Aziende farmaceutiche
- Altre
ePRO, diari ePatient e mercato eCOA - per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
< li>Europa - Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto dell'Europa
- Asia Pacifico (APAC)
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'Asia Pacifico
- Medio Oriente e Asia Africa (MEA)
- Sudafrica
- Arabia Saudita
- Emirati Arabi Uniti
- Resto del Medio Oriente e dell'Africa. Africa
- America del Sud (SAM)
- Brasile
- Argentina
- Resto dell'America meridionale e centrale< /li>
Profili aziendali
- ERT Clinical
- ArisGlobal LLC
- Il diario Pte. Ltd
- ICON PLC
- PAREXEL INTERNATIONAL CORPORATION
- Anju Software, Inc.
- Kayentis
- Bracket Global LLC
- Dassault Systèmes SE
- CRF Salute
- Soluzioni eClinical
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies - ePRO ePatient Diaries and eCOA Market
- ERT Clinical
- ArisGlobal LLC
- The Diary Pte. Ltd
- ICON PLC
- PAREXEL INTERNATIONAL CORPORATION
- Anju Software, Inc.
- Kayentis
- Bracket Global LLC
- Dassault Systèmes SE
- CRF Health
- eClinical Solutions
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
May 2021
Emergency Call Systems Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Fall Prevention and Detection, Workflow Optimization, Patient Care Reminders, Alarms and Communication Management, Wander Management, Reporting and Analytics, Real-Time Staff Locating, and Others), End User (Hospital and Clinics, Assisted Living and Independent Living Facilities, Ambulatory Surgical Centers, and Others), Technology (Wired and Wireless), Offering (Hardware, Software, and Services), Product Type (Nurse Call Systems, Call Box Systems, Emergency Stanchions, Intercom System, and Others),, and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
Outpatient Central Fulfillment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Automated Medication Dispensing Systems, Automated Packaging and Labeling Systems, Automated Tabletop Counters, Automated Storage and Retrieval Systems, and Others), End User (Hospital Pharmacies, Retail Pharmacies, and Mail-Order Pharmacies), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
May 2021
Well-Being Platform Market
Forecast to 2030 - Global Analysis by Service (Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition & Weight Management, Stress Management, Comprehensive Well-Being, and Others), Category (Fitness and Nutrition Consultant, Psychological Therapists, and Organizations/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organizations, and Home Use), and Geography
May 2021
Product Design and Development Services Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Services (Research, Strategy, and Concept Generation; Concept and Requirement Development; Detailed Design and Process Development; Process Validation, Manufacturing Transfer, and Design Validation; and Other Services), Application (Diagnostic Equipment, Therapeutic Equipment, Surgical Instruments, Clinical Laboratory Equipment, Biological Storage, Consumables, and Others), and End User (Medical Companies, Pharmaceutical Companies, Biotechnology Companies, and Contract Research Organizations)
May 2021
Patient Engagement Technology Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Component (Services, Hardware, and Software), Therapeutic Area (Fitness, Chronic Diseases, Women’s Health, and others), Delivery Mode (Cloud-Based and On-Premises), Application (Health Management, Financial Health Management, Home Healthcare Management, and Others), and End User (Patients, Payers, Providers, and Others)
May 2021
IVD Contract Research Organization Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Clinical Chemistry, Molecular Diagnostics, Immunochemistry, Companion Diagnostics, Hematology, Histology & Cytology, Microbiology, and Others), Services (Clinical Research, Biostatistics & Data Management Services, Therapeutic Expertise, Regulatory Services, Reimbursement Support Services, Assay Development Services, and Others), and Geography
May 2021
Dental CAD/CAM Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Dental CAD/CAM Materials (Glass Ceramics, Alumina-Based Ceramics, Lithium Disilicate, Zirconia, and Others) and Dental CAD/CAM Systems], Type (In-Office Systems and In-Lab Systems), Components [Hardware (Dental Printers, Milling Machines, Scanners, and Others) and Software], Application (Dental Prosthesis, Dental Implants, and Others), and End User (Dental Clinics, Dental Laboratories, Milling Centers, and Others)
May 2021
Emergency Medical Software Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product [Early Warning and Vulnerability Alert System (EWVAS), EMS Computer Aided Dispatch (CAD) System, Incident Response Software, Ambulance Management Software, and Others], Mode of Delivery [On Premises and Software as a Service (SaaS)], Platform (Android, iOS, Windows, and Others), and End User (Commercial, Municipal, State City Agencies, and Others)